Maple Rock Capital Partners Inc. Teva Pharmaceutical Industries LTD Transaction History
Maple Rock Capital Partners Inc.
- $2.95 Billion
- Q2 2024
A detailed history of Maple Rock Capital Partners Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 4,512,401 shares of TEVA stock, worth $77.2 Million. This represents 2.49% of its overall portfolio holdings.
Number of Shares
4,512,401
Previous 4,363,401
3.41%
Holding current value
$77.2 Million
Previous $61.6 Million
19.1%
% of portfolio
2.49%
Previous 3.41%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
565MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$736 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$622 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$553 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$493 Million3.23% of portfolio
-
Exor Capital LLP London, X026.5MShares$453 Million15.49% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...